Peptide Stapling: How Chemical 'Staples' Lock Drug Molecules Into Their Active Shape
Hydrocarbon stapling has become the leading method for stabilizing peptide drugs by locking them into spiral shapes that resist degradation, penetrate cells, and hit hard-to-drug targets.
Quick Facts
What This Study Found
Hydrocarbon stapling — using a chemical 'staple' to lock peptides into their spiral (alpha-helical) shape — has become the most widely adopted peptide stabilization strategy. The technique uses ruthenium-catalyzed ring-closing metathesis, a chemical reaction that forms a hydrocarbon bridge across one face of the peptide helix.
Recent advances include multiple-stapling (more than one staple per peptide), stitched peptides, aza-stapled peptides, and the integration of rigid anchoring amino acids that expand structural diversity. New modifications also enable imaging capabilities, such as Raman-active diyne bridges for diagnostic applications.
Key Numbers
Most widely adopted stapling method · Ruthenium-catalyzed RCM · Strategies: mono-stapling, multi-stapling, stitched, aza-stapled · Compatible with solid-phase peptide synthesis
How They Did This
Review article summarizing advancements in hydrocarbon stapled peptide technology, covering synthetic strategies, structural innovations, and therapeutic/diagnostic applications.
Why This Research Matters
Regular peptides are floppy and get chewed up by enzymes in the body, limiting their use as drugs. Stapling locks them into their active shape, making them more stable, better at crossing cell membranes, and more biologically potent. This matters because stapled peptides can target protein-protein interactions — a class of drug targets that traditional small molecules largely can't reach, opening up treatment possibilities for cancers and other diseases.
The Bigger Picture
Stapled peptides represent one of the most active areas in peptide drug development. By solving the stability and cell-penetration problems that plague regular peptides, stapling technology is enabling an entire new class of drugs that can reach previously 'undruggable' targets inside cells. Several stapled peptide candidates are in clinical trials, particularly for cancers driven by protein-protein interactions.
What This Study Doesn't Tell Us
As a review, no new experimental data is presented. The review focuses on chemical methodology and may not fully address in vivo efficacy or clinical translation challenges. Many stapled peptide candidates are still in early development.
Questions This Raises
- ?Which stapled peptide drug candidates are closest to FDA approval?
- ?Can multi-stapling strategies improve oral bioavailability enough for pill-form stapled peptide drugs?
- ?How do stapled peptides compare to cyclic peptides for targeting intracellular protein-protein interactions?
Trust & Context
- Key Stat:
- Most widely adopted stapling method Hydrocarbon stapling via ring-closing metathesis remains the dominant approach for stabilizing peptide drugs, enhancing their resistance to degradation and ability to enter cells
- Evidence Grade:
- This is a comprehensive chemistry review covering synthetic strategies and structural innovations in peptide stapling. It synthesizes advances across the field without presenting new experimental data.
- Study Age:
- Published in 2025, this is a very current review capturing the latest innovations in peptide stapling technology, including novel modifications like Raman-active bridges for imaging applications.
- Original Title:
- Advances in Hydrocarbon Stapled Peptides via Ring-Closing Metathesis: Synthetic Strategies, Structural Diversity, and Therapeutic Applications.
- Published In:
- Chembiochem : a European journal of chemical biology, 26(23), e202500527 (2025)
- Authors:
- Li, Linji, Li, Rong(5), Jiang, Yanan, Chao, Jingru, Chen, Si, Liao, Hongli, Li, Xiang
- Database ID:
- RPEP-12079
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is peptide stapling and why is it important?
Peptide stapling is a technique that inserts a chemical bridge (a 'staple') across a peptide to lock it into its active spiral shape. Without stapling, peptides are floppy and get destroyed by enzymes in the body. Stapled peptides are more stable, can cross cell membranes, and are more biologically active — making them viable drug candidates for previously untreatable diseases.
What kind of diseases could stapled peptides treat?
Stapled peptides are particularly promising for cancers and diseases driven by protein-protein interactions — molecular handshakes between proteins that conventional small-molecule drugs can't disrupt. By stabilizing the peptide's shape and enabling cell penetration, stapling allows these drugs to get inside cells and break apart disease-driving protein complexes.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-12079APA
Li, Linji; Li, Rong; Jiang, Yanan; Chao, Jingru; Chen, Si; Liao, Hongli; Li, Xiang. (2025). Advances in Hydrocarbon Stapled Peptides via Ring-Closing Metathesis: Synthetic Strategies, Structural Diversity, and Therapeutic Applications.. Chembiochem : a European journal of chemical biology, 26(23), e202500527. https://doi.org/10.1002/cbic.202500527
MLA
Li, Linji, et al. "Advances in Hydrocarbon Stapled Peptides via Ring-Closing Metathesis: Synthetic Strategies, Structural Diversity, and Therapeutic Applications.." Chembiochem : a European journal of chemical biology, 2025. https://doi.org/10.1002/cbic.202500527
RethinkPeptides
RethinkPeptides Research Database. "Advances in Hydrocarbon Stapled Peptides via Ring-Closing Me..." RPEP-12079. Retrieved from https://rethinkpeptides.com/research/li-2025-advances-in-hydrocarbon-stapled
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.